DNA structures at chromosomal translocation sites

BioEssays

Volumn 28, Issue 5, 2006, Pages 480-494

  Raghavan, Sathees C ^a   Lieber, Michael R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; PROTEIN BCL 2;

CHROMOSOME FRAGILITY; CHROMOSOME TRANSLOCATION; DNA SEQUENCE; DNA STRUCTURE; LYMPHOID CELL; REVIEW; T CELL LEUKEMIA;

CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN; DNA; DNA DAMAGE; GENES, BCL-2; HUMANS; LEUKEMIA, T-CELL; LYMPHOCYTES; NUCLEIC ACID CONFORMATION; TRANSLOCATION, GENETIC;

EID: 33646359685     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20353     Document Type: Review

References (103)

1. Lewis SM. 1994. The Mechanism of V(D)J Joining: Lessons from Molecular, Immunological and Comparative Analyses. Adv Imm 56:27-150.
2. Lieber MR. 1993. The role of site-directed recombinases in physiologic and pathologic chromosomal rearrangements. In: Kirsch I, editor. The Causes and Consequences of Chromosomal Aberrations. Boca Raton: CRC Press. p 239-275.
3. Raghavan SC, Lieber MR. 2004. Chromosomal translocations and non-B DNA structures in the human genome. Cell Cycle 3:762-768.
4. Look AT. 1997. Oncogenic Transcription Factors in Human Acute Leukemias. Science 278:1059-1064.
5. Kirsch IR, editor. 1993. The Causes and Consequences of Chromosomal Translocations. Boca Raton, FL: CRC. 534 p.
6. Bakhshi A, Wright JJ, Graninger W, Seto M, Owens J, et al. 1987. Mechanism of the t(14;18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci 84:2396-2400.
7. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, et al. 1985. Cloning the Chromosomal Breakpoint of t(14;18) Human Lymphomas: Clustering Around JH on Chromosome 14 and Near a Transcription Unit on 18. Cell 41:899-906.
8. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, et al. 1986. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97-106.
9. Tsujimoto Y, Gorham J, Cossman F, Jaffe E, Croce CM. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393.
10. Jager U, Bocskor S, Le T, Mitterbauer G, Bolz I, et al. 2000. Follicular lymphomas BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95:3520-3529.
11. Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG. 1992. BCL2 oncogene translocation is mediated by a ?-like consensus. J Exp Med 175:1575-1588.
12. Korsmeyer SJ. 1992. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10:785-807.
13. Albinger-Hegyi A, Hochreutener B, Abdou M, Hegyi I, Dours-Zimmerman M, et al. 2002. High Frequency of t(14;18)-Translocation Breakpoints Outside of Major Breakpoint and Minor Cluster Regions in Follicular Lymphomas. Am J Path 160:823-832.
14. Schatz DG, Oettinger MA, Schlissel MS. 1992. V(D)J recombination: Molecular biology and regulation. Ann Rev Immunol 10:359-383.
15. Oettinger MA, Schatz DG, Gorka C, Baltimore D. 1990. Rag-1 and Rag-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523.
16. Schatz DG, Oettinger MA, Baltimore D. 1989. The V(D)J recombination activating gene, RAG-1. Cell 59:1035-1048.
17. Sawchuk D, Weis-Garcia F, Malik S, Besmer E, Bustin M, et al. 1997. V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins. J Exp Med 185:2025-2032.
18. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Ann Rev Immunol 18:495-527.
19. Lieber MR, Ma Y, Pannicke U, Schwarz K. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nature Rev Mol Cell Biol 4:712-720.
20. Roth DB. 2003. Restraining the V(D)J recombinase. Nat Rev Immunol 3:656-666.
21. Swanson PC. 2004. The bounty of RAGs: recombination signal complexes and reaction outcomes. Immunolog Rev 200:90-114.
22. Jung D, Alt FW. 2004. Unraveling V(D)J recombination; insights into gene regulation. Cell 116:299-311.
23. Gellert M. 2002. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 71:101-132.
24. Bassing CH, Alt FW. 2004. The cellular response to general and programmed DNA double-strand breaks. DNA Repair 3:781-796.
25. Raghavan SC, Kirsch IR, Lieber MR. 2001. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J Biol Chem 276:29126-29133.
26. Marculescu R, Le T, Simon P, Jaeger U, Nadel B, 2002. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites. J Exp Med 195:85-98.
27. Lewis SM, Agard E, Suh S, Czyzyk L. 1997. Cryptic signals and the fidelity of V(D)J Joining. Mol Cell Biol 17:3125-3136.
28. Kitagawa Y, Inoue K, Sasaki S, Hayashi Y, Matsuo Y, et al. 2002. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia. J Biol Chem 277:46289-46297.
29. Cleary ML, Sklar J. 1985. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443.
30. Raghavan SC, Swanson PC, Wu X, Hsieh C-L, Lieber MR. 2004a. A non-B-DNA structure at the Bcl-2 major break point region is cleaved by the RAG complex. Nature 428:88-93.
31. Elliott B, Jasin M. 2002. Double-strand breaks and translocations in cancer. Cell Mol Life Sci 59:373-385.
32. Sinden RR. 1994. DNA Structure and Function. San Diego: Academic Press. 398 p.
33. Soyfer VN, Potaman VN. 1996. Triple-Helical Nucleic Acids. New York: Springer-Verlag. 360 p.
34. Bacolla A, Wells RD. 2004. Non-B DNA conformations, genomic rearrangements, and human disease. J Biol Chem 279:47411-47414.
35. Majumdar A, Patel DJ. 2002. Identifying hydrogen bond alignments in multistranded DNA architectures by NMR. Acc Chem Res 35:1-11.
36. Gilbert DE. Feigon J. 1999. Multistranded DNA structures. Curr Opin Stru Biol 9:305-314
37. Lilley DMJ, Dahlberg JE, editors. 1992. DNA Structures Part B: Chemical and Electrophoretic Analysis of DNA. In: Abelson JN, Simon MI, editors Methods in Enzymology, Vol. 212. San Diego: Academic Press, Inc.
38. Lilley DMJ, Dahlberg JE, editors. 1992. DNA Structures Part A: Synthesis and Physical Analysis of DNA. In: Abelson JN, Simon MI, ediors. Methods in Enzymology, Vol. 211. San Diego: Academic Press, Inc.
39. Rich A, Zhang S. 2003. Timeline: Z-DNA: the long road to biological function. Nat Rev Genet 7:566-572.
40. Felsenfeld G, Davies DR, Rich A. 1957. Formation of a three-stranded polynucleotide molecule. J Am Chem Soc 79:2023-2024.
41. Frank-Kamenetskii MD, Mirkin SM. 1995. Triplex DNA structures. Ann Rev Biochem 64:65-95.
42. Raghavan SC, Chastain P, Lee JS, Hegde BG, Houston S, et al. 2005c. Evidence for a triplex DNA conformation at the bcl-2 Major breakpoint region of the t(14;18) translocation. J Biol Chem 280:22749-22760.
43. Kohwi Y, Kohwi-Shigematsu T. 1988. Magnesium ion-dependent triple-helix structure formed by homopurine-homopyrimidine sequences in supercoiled plasmid DNA. Proc Natl Acad Sci 85:3781-3785.
44. Kramer PR, Sinden RR. 1997. Measurement of unrestrained negative supercoiling and topological domain size in living human cells. Biochemistry 36:3151-3158.
45. Baran N, Lapidot A, Manor H. 1991. Formation of DNA triplexes account for arrests of DNA synthesis at d(TC)n and d(GA)n tracts. Proc Natl Acad Sci 88:507-511.
46. Neidle S, Parkinson GN. 2003. The structure of telomeric DNA. Curr Opin Stru Biol 3:275-283.
47. Yu K, Chedin F, Hsieh C-L, Wilson TE, Lieber MR. 2003. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nature Immunol 4:442-451.
48. Shinkura R, Tian M, Khuong C, Chua K, Pinaud E, et al. 2003. The influence of transcriptional orientation on endogenous switch region function. Nature Immunol 4:435-441.
49. Duquette ML, Handa P, Vincent JA, Taylor AF, Maizels N. 2004. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev 18:1618-1629.
50. Raghavan SC, Houston S, Hegde BG, Langen R, Haworth IS, et al. 2004b. Stability and strand asymmetry in the non-B DNA structure at the bcl-2 major breakpoint region. J Biol Chem 279:46213-46225.
51. Shimizu M, Fujita R, Tomita N, Shindo H, Wells RD. 2001. Chromatin structure of yeast minichromosomes containing triplet repeat sequences associated with human hereditary neurological diseases. Nucleic Acids Res Suppl 1:71-72.
52. Jakupciak JP, Wells RD 2000. Genetic instabilities of triplet repeat sequences by recombination. IUBMB Life 50:355-359.
53. Dayn A, Samadashwily GM, Mirkin SM. 1992. Intramolecular DNA triplexes: unusual seqeunce requirements and influence on DNA polymerization Proc Natl Acad Sci 89:11406-11410.
54. Mirkin SM, Lyamichev VI, Drushlyak KN, Dobrynin VN, Filippov SA, et al. 1987. DNA H-form requires a homopurine-homopyrimidine mirror repeat. Nature 330:495-497.
55. Sakamoto N, Chastian PD, Parniewski P, Ohshima K, Pandolfo M, et al. 1999. Sticky DNA: Self-Association Properties of Long GAA.TTC Repeats in R.R.Y. Triplex Structures from Friedreich's Ataxia. Mol Cell 3:465-475.
56. Gacy AM, Goellner GM, Spiro C, Chen X, Gupta G, et al. 1998. GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. Mol Cell 1:583-593.
57. Potaman VN, Oussatcheva EA, Lyubchenko YL, Shlyakhtenko LS, Bidichandani SI, et al. 2004. Length-dependent structure formation in Friedreich ataxia (GAA)n.(TTC)n repeats at neutral pH. Nucleic Acids Res 32:1224-1231.
58. Bacolla A, Jaworski A, Larson JE, Jakupciak JP, Chuzhanova N, et al. 2004. Breakpoints of gross deletions coincide with non-B DNA conformations Proc Natl Acad Sci 101:14162-14167.
59. Gotter AL, Shaikh TH, Budarf ML, Rhodes CH, Emanuel BS. 2004. A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2. Hum Mol Genet 13:103-115.
60. Repping S, Skaletsky H, Lange J, Silber S, Veen FVD, et al. 2002. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 71:906-922.
61. Sinden RR. 1999. Biological implications of the DNA structures associated with disease causing triplet repeats. Am J Hum Genet 64:346-353.
62. Raghavan SC, Swanson PC, Ma Y, Lieber MR. 2005a. Double-strand break formation by the RAG complex at the bcl-2 Mbr and at other non-B DNA structures in vitro. Mol Cell Biol 25:5904-5919.
63. Raghavan SC, Hsieh C-L, Lieber MR. 2005b. Both V(D)J coding ends but neither signal end can recombine at the bcl-2 major breakpoint region and the rejoining is ligase IV dependent. Mol Cell Biol 25:6475-6484.
64. Hiom K, Gellert M. 1997. A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell 88:65-72
65. Agrawal A, Schatz DG. 1997. RAG1 and RAG2 form a stable post-cleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 89:43-53.
66. Agrawal A, Eastman QM, Schatz DG. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394:744-751
67. Hiom K, Melek M, Gellert M. 1998. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 94:463-470
68. Messier TL, O'Neill JP, Hou S-M, Nicklas JA, Finette BA. 2003. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes. EMBO J 22:1381-1388.
69. Ramsden DA, McBlane JF, Gent DCV, Gellert M. 1996. Distinct DNA sequence and structure requirements for the two steps of V(D)J recombination signal cleavage. EMBO J 15:3197-3206.
70. Besmer E, Mansilla-Soto J, Cassard S, Sawchuk DJ, Brown G, et al. 1998. Hairpin coding end opening is mediated by the recombination activating genes RAG1 and RAG2. Molecular Cell 2:817-828.
71. Shockett PE, Schatz DG. 1999. DNA hairpin opening mediated by the RAG1 and RAG2 proteins. Mol Cell Biol 19:4159-4166.
72. Grawunder U, Lieber MR. 1997. A complex of RAG-1 and RAG-2 persists on the DNA after single-strand cleavae at V(D)J recombination signal sequences. Nucl Acids Res 25:1375-1382.
73. Santagata S, Besmer E, Villa A, Bozzi F, Allingham J, et al. 1999. The RAG1/RAG2 complex constitutes a 3′ flap endonuclease: implications for junctional diversity in V(D)J and transpositional recombination. Mol Cell 4:935-947.
74. Hesse JE, Lieber MR, Mizuuchi K, Gellert M. 1989. V(D)J recombination: a functional definition of the joining signals. Genes and Development 3:1053-1067
75. Ma Y, Pannicke U, Schwarz K, Lieber MR. 2002. Hairpin opening and overhang processing by an Artemis:DNA-PKcs complex in V(D)J recombination and in nonhomologous end joining. Cell 108:781-794.
76. Lin W-C, Desiderio S. 1994. Cell cycle regulation of RAG-2 V(D)J recombinase. Proc Natl Acad Sci USA 91:2733-2737.
77. Petrovic AS, Young RL, Hilgarth B, Ambros P, Korsmeyer SJ, et al. 1998. The Ig heavy chain 3′ end confers a posttranscriptional processing advantage to Bcl-2-IgH fusion RNA in t(14;18) lymphoma. Blood 91:3952-3961.
78. Max EE. 1999. Immunoglobulins: Molecular Genetics. In: Paul WE, editor. Fundamental Immunology. Lippincott Raven: Philadelphia, p 111-182.
79. Muramatsu M, Sankaranand V, Anant S, Sugai M, Kinoshita K, et al. 1999. Specific Expression of Activation-Induced Cytidine Deaminase (AID), a Novel Member of the RNA-Editing Deaminase Family in Germinal Center B Cells. J Biol Chem 274:18470-18476.
80. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. 2000. Class switch recombination and somatic hypermutation require activation-induced cytidine deaminase (AID), a member of the RNA editing cytidine deaminase family. Cell 102:541-544.
81. Chaudhuri J, Alt FW. 2004. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 4:541-552.
82. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, et al. 1988. Alternative promoters and exons, somatic mutation and deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J 7:123-131.
83. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, et al. 1998. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95:11816-11821.
84. Melek M, Gellert M. 2000. RAG 1/2-mediated resolution of transposition intermediates: two pathways and possible consequences. Cell 101:625-633.
85. Tsai CL, Schatz DG. 2003. Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2. EMBO J 22:1922-1930.
86. Elkin SK, Matthews AG, Oettinger MA. 2003. The C-terminal portion of RAG2 protects against transposition in vitro. EMBO J 8:1931-1938.
87. Swanson PC, Volkmer D, Wang L. 2004. Full-length RAG-2, and not full-length RAG1, specifically suppress RAG-mediated transposition but not hybrid joint formation or disintegration. J Biol Chem 279:4034-4044.
88. Lewis S, Hesse JE, Mizuuchi K, Gellert M. 1988. Novel strand exchanges in V(D)J recombination. Cell 55:1099-1107.
89. Sekiguchi J, Whitlow S, Alt FW. 2001. Increased accumulation fo hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. Mol Cell 8:1383-1390.
90. Melek M, Gellert M, Gent DCv. 1998. Rejoining of DNA by the RAG1 and RAG2 proteins. Science 280:301-303.
91. Bogue MA, Jhappan C, Roth DB. 1998. Analysis of V(D)J recombination in DNA-PK-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc Natl Acad Sci 95:15559-15564.
92. Han J-O, Steen SB, Roth DB. 1997. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol Cell Biol 17:2226-2234.
93. Bogue MA, Wang C, Zhu C, Roth DB. 1997. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity 7:37-47.
94. Raghavan SC, Tong J, Lieber MR. 2006. Hybrid joint formation in human V(D)J recombination requires nonhomologous DNA end joining. DNA Repair 5:278-285.
95. Nishihara T, Nagawa F, Nishizumi H, Kodama M, Hirose S, et al. 2004. In vitro processing of the 3′-overhanging DNA in the postcleavage complex involved in V(D)J joining. Mol Cell Biol 24:3692-3702.
96. Lee GS, Neiditch MB, Sinden RR, Roth DB. 2002. Targeted transposition by the V(D)J recombinase. Mol Cell Biol 22:2068-2077.
97. Tsai CL, Chatterji M, Schatz DG. 2003. DNA mismatches and GC-rich motifs target transposition by the RAG1/RAG2 transposase. Nucleic Acids Res 31:6180-6190.
98. Lee GS, Neiditch MB, Salus SS, Roth DB. 2004. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 16:171-184.
99. Seiter K. 2005. Toxicity of the topoisomerase II inhibitors. Expert Opin Drug Saf 4:219-234.
100. Karanjawala ZE, Murphy N, Hinton DR, Hsieh C-L, Lieber MR. 2002. Oxygen metabolism causes chromosome breaks and is associated with the neuronal apoptosis observed in double-strand break repair mutants. Current Biol 12:397-402.
101. Lieber MR, Karanjawala ZE. 2004. Ageing, repetitive genomes and DNA damage. Nature Rev Mol Cell Biol 5:69-75.
102. Myung K, Datta A, Kolodner RD. 2001. Suppression of spontaneous chromosomal rearrangements by S phase checkpoint functions in Saccharomyces cerevisiae. Cell 104:397-408.
103. Tanaka H, Bergstrom D, Yao MC, Tapscott SJ. 2005. Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification. Nat Genet 37:320-327.